01.04.2021
SMID caps set to outperform in a recovery scenario
Bilan (31.03.2021) - As vaccines offer a way out of the current crisis, we should see a greater rebound among small and mid-cap companies, the so-called ‘SMID-cap’ segment, than in the broader market.